SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-16-038625
Filing Date
2016-09-13
Accepted
2016-09-13 16:04:34
Documents
28
Period of Report
2016-10-27
Effectiveness Date
2016-09-13

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A tech20160908_def14a.htm DEF 14A 836031
2 a2.jpg GRAPHIC 147130
3 a1.jpg GRAPHIC 161032
4 a26.jpg GRAPHIC 13857
5 a25.jpg GRAPHIC 13010
6 a23.jpg GRAPHIC 5677
7 a22.jpg GRAPHIC 3936
8 a21.jpg GRAPHIC 6536
9 a20.jpg GRAPHIC 3951
10 a19.jpg GRAPHIC 6397
11 a18.jpg GRAPHIC 3915
12 a17.jpg GRAPHIC 11183
13 a16.jpg GRAPHIC 9588
14 a15.jpg GRAPHIC 11082
15 a14.jpg GRAPHIC 9214
16 a13.jpg GRAPHIC 11291
17 a12.jpg GRAPHIC 9432
18 a11.jpg GRAPHIC 11579
19 a10.jpg GRAPHIC 9593
20 a9.jpg GRAPHIC 12005
21 a8.jpg GRAPHIC 9576
22 a7.jpg GRAPHIC 11288
23 a6.jpg GRAPHIC 9718
24 a24.jpg GRAPHIC 777
25 tech20160908_def14aimg003.gif GRAPHIC 1488
26 a4.jpg GRAPHIC 23932
27 a3.jpg GRAPHIC 7433
28 tech20160908_def14aimg002.jpg GRAPHIC 7111
  Complete submission text file 0001437749-16-038625.txt   1570719
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

IRS No.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 000-17272 | Film No.: 161882917
SIC: 2836 Biological Products, (No Diagnostic Substances)